NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease

被引：6

作者：

Painuli, Sakshi ^{[1
,2
]}

Semwal, Prabhakar ^{[2
]}

Zam, Wissam ^{[3
]}

Taheri, Yasaman ^{[4
]}

Ezzat, Shahira M. ^{[5
,6
]}

Zuo, Peijun ^{[7
]}

Li, Liping ^{[7
]}

Kumar, Dileep ^{[8
]}

Sharifi-Rad, Javad ^{[9
,13
]}

Cruz-Martins, Natalia ^{[10
,11
,12
,14
]}

机构：

[1] Himalayan Environm Studies & Conservat Org HESCO, Dehra Dun 248006, India

[2] Graphic Era Deemed be Univ, Dept Life Sci, Dehra Dun 248002, India

[3] Tartous Univ, Fac Pharm, Dept Analyt & Food Chem, Tartous, Syria

[4] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran

[5] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11562, Egypt

[6] October Univ Modern Sci & Arts MSA, Fac Pharm, Dept Pharmacognosy, Giza 12451, Egypt

[7] Shantou Univ, Sch Publ Hlth, Shantou, Guangdong, Peoples R China

[8] Bharati Vidyapeeth Deemed be Univ, Poona Coll Pharm, Pune 411038, Maharashtra, India

[9] Univ Azuay, Fac Med, Cuenca, Ecuador

[10] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal

[11] Univ Porto, Inst Res & Innovat Hlth i3S, P-4200135 Porto, Portugal

[12] Inst Res & Adv Training Hlth Sci & Technol CESPU, Rua Cent Gandra 1317, P-4585116 Gandra, Portugal

[13] Univ Azuay, Fac Med, Cuenca, Ecuador

[14] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal

来源：

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2023年 / 26卷 / 12期

关键词：

Alzheimer's disease; neurodegeneration; N-methyl D-aspartate (NMDA) receptors; precision medicine; NMDA; dimensia; METHYL-D-ASPARTATE; AMYLOID PRECURSOR PROTEIN; LONG-TERM-POTENTIATION; A-BETA ACCUMULATION; APOLIPOPROTEIN-E; SYNAPTIC PLASTICITY; MODERATELY SEVERE; TYROSINE PHOSPHORYLATION; RECEPTOR ANTAGONIST; GLUTAMATE TOXICITY;

D O I：

10.2174/1386207325666220428112541

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Alzheimer's disease (AD) is an increasingly common neurodegenerative disease that attracts the attention of researchers and medical community in order to develop new, safe and more effective drugs. Currently available drugs could only slow the AD progression and relieve the symptoms, in addition to being linked to moderate-to-severe side effects. N-methyl D-aspartate (NMDA) receptors antagonists were reported to have the ability to block the glutamate-mediated excitotoxic activity being good therapeutic targets for several neurodegenerative diseases, including AD. Based on data obtained so far, this review provides an overview over the use of NMDA antagonists for AD treatment, starting with a key emphasis on present features and future aspects regarding the use of NMDA antagonists for AD, and lastly a key focus is also given on its use in precision medicine.

引用

页码：2099 / 2112

页数：14

共 50 条

[21] The potential for BACE1 inhibitors in the treatment of Alzheimer's disease
Hussain, I
IDRUGS, 2004, 7 (07) : 653 - 658
[22] GSK-3 inhibitors and their potential in the treatment of Alzheimer's disease
Kypta, RM
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (10) : 1315 - 1331
[23] Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
Konrath, Eduardo Luis
Passos, Carolina dos Santos
Klein-Junior, Luiz Carlos
Henriques, Amelia T.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (12) : 1701 - 1725
[24] Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease
Xi, Meiyang
Sun, Tianyu
Chai, Shejie
Xie, Mengjiao
Chen, Siqi
Deng, Liping
Du, Kui
Shen, Runpu
Sun, Haopeng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232
[25] Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer’s Disease
Ewa Baranowska-Wójcik
Dominik Szwajgier
Anna Winiarska-Mieczan
Plant Foods for Human Nutrition, 2020, 75 : 30 - 32
[26] Potential cardioprotective effects of acetylcholinesterase inhibitors in patients with Alzheimer's disease
Rampa, L.
Gaspardone, C.
Fiore, G.
Romagnolo, D.
Cerutti, A.
Santangelo, R.
Magnani, M.
Piscazzi, G.
Sgherzi, G.
Filippi, M.
Margonato, A.
Fragasso, G.
EUROPEAN HEART JOURNAL, 2023, 44
[27] Screening of Common Potential Inhibitors against Periodontitis and Alzheimer's Disease
Khan, Mahvish
Khan, Saif
Lohani, Mohtashim
Alhobeira, Hazza A.
Mirza, Shadab
Haque, Shafiul
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (24B) : 83 - 91
[28] Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease
Bhatia, Shiveena
Singh, Manjinder
Singh, Tanveer
Singh, Varinder
NEUROCHEMICAL RESEARCH, 2023, 48 (01) : 13 - 25
[29] The potential role of nutritional components in the management of Alzheimer's Disease
van der Beek, Eline M.
Kamphuis, Patrick J. G. H.
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (01) : 197 - 207
[30] An Overview on Potential Neuroprotective Compounds for Management of Alzheimer's Disease
Sheikh, Ishfaq Ahmed
Ali, Riyasat
Dar, Tanveer A.
Kamal, Mohammad Amjad
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (08) : 1006 - 1011

← 1 2 3 4 5 →